2+ -calmodulin-dependent protein kinase II (CaMKII) plays an important role mediating apoptosis/ necrosis during ischemia-reperfusion (IR). We explored the mechanisms of this deleterious effect. Langendorff perfused rat and transgenic mice hearts with CaMKII inhibition targeted to sarcoplasmic reticulum (SR-AIP) were subjected to global IR. The onset of reperfusion increased the phosphorylation of Thr 17 site of phospholamban, without changes in total protein, consistent with an increase in CaMKII activity. Instead, there was a proportional decrease in the phosphorylation of Ser2815 site of ryanodine receptors (RyR2) and the amount of RyR2 at the onset of reperfusion, i.e. the ratio Ser2815/RyR2 did not change. Inhibition of the reverse Na + /Ca 2+ exchanger (NCX) mode (KBR7943) diminished phospholamban phosphorylation, reduced apoptosis/necrosis and enhanced mechanical recovery. CaMKII-inhibition (KN-93), significantly decreased phospholamban phosphorylation, infarct area, lactate dehydrogenase release (LDH) (necrosis), TUNEL positive nuclei, caspase-3 activity, Bax/Bcl-2 ratio and Ca 2+ -induced mitochondrial swelling (apoptosis), and increased contractile recovery when compared with non-treated IR hearts or IR hearts pretreated with the inactive analog, KN-92. Blocking SR Ca 2+ loading and release (thapsigargin/dantrolene), mitochondrial Ca 2+ uniporter (ruthenium red/RU360), or mitochondrial permeability transition pore (cyclosporine A), significantly decreased infarct size, LDH release and apoptosis. SR-AIP hearts failed to show an increase in the phosphorylation of Thr 17 of phospholamban at the onset of reflow and exhibited a significant decrease in infarct size, apoptosis and necrosis respect to controls. The results reveal an apoptotic-necrotic pathway mediated by CaMKII-dependent phosphorylations at the SR, which involves the reverse NCX mode and the mitochondria as trigger and end effectors, respectively, of the cascade.
Introduction

Ca
2+
-calmodulin-dependent protein kinase II (CaMKII) is a serine/ threonine protein kinase which phosphorylates several proteins of the excitation-contraction coupling [1] [2] [3] [4] [5] . CaMKII has also been shown to be involved in the pathogenesis of hypertrophy and heart failure [6] . Recent experiments from our laboratory revealed a dual role of CaMKII during the injury induced by ischemia/reperfusion (IR). It was shown that CaMKII plays a beneficial role in the reversible IR dysfunction, also known as stunned heart [7] [8] [9] . The protective role of CaMKII was mainly mediated by phosphorylation of the Thr 17 site of phospholamban (PLN), the sarcoplasmic reticulum (SR) protein that regulates the function of SR-Ca 2+ -ATPase (SERCA2a). Phosphorylation of Thr 17 at the onset of reperfusion was necessary to ameliorate Ca 2+ mishandling and mechanical recovery in the stunned heart [8, 9] . However, if the ischemic period was extended, a detrimental effect of CaMKII activation became evident, manifested by an increase in apoptosis/necrosis and an impairment of contractile function, which were abrogated by CaMKII-inhibition [10, 11] . Pioneer studies by Zhu et al. [12] demonstrated that β 1 adrenoceptor-induced apoptosis was independent of cAMP and PKA signalling but requires the involvement of a CaMKII-mediated cascade. It was further shown that overexpression of CaMKII results in a profound contractile impairment with major alterations in intracellular Ca 2+ handling and pronounced increase in suggested a CaMKII-dependent SR-Ca 2+ mishandling involved in the detrimental effect of IR injury [11] , these experiments were performed in isolated myocytes subjected to simulated IR injury, an approach that can only partially mimic the IR process in the intact heart. Besides, the signalling pathways by which CaMKII activation produces apoptosis and necrosis during IR remain unknown. The present experiments were undertaken to gain further insights into the mechanisms of the deleterious effects of CaMKII in the irreversible IR injury. It will be shown that two main players in the signalling cascade by which CaMKII mediates apoptosis and necrosis during IR are the SR and the mitochondria.
Materials and methods
Animals
Experiments were performed in Wistar male rats (200-300 g). A set of the experiments was performed in transgenic mice, (25-30 g ) expressing four concatenated repeats of the CaMKII autocamtide inhibitory peptide (AIP) selectively at the SR membranes (SR-AIP) [15] . Age-matched wild type mice (WT) served as controls. The mouse transgenic model was used to specifically test the role of CaMKIIdependent phosphorylations at the SR [15] . All animals used were maintained in accordance with the Guide for the Care and Use of Laboratory Animals [NIH Publication No. 85-23, revised 1996].
Langendorff perfusion and experimental protocol
Isolated hearts were perfused according to the Langendorff technique [2, 8] . Hearts were subjected to 45 min of global ischemia followed by 120 min of reperfusion. All drugs used were administrated 10 min before ischemia and during the first 10 min of reperfusion. Details of methods and the effect of the different treatments on basal contractility are provided in the Online Supplementary Data.
Infarct size
After reperfusion, infarct size was assessed by the triphenyltetrazolium chloride (TTC) technique.
LDH determination
Cardiac injury was evaluated by LDH released in the perfusion effluent during the first 10 min of reperfusion.
Terminal deoxynucleotidyl transferase-mediated dUTP nick-end (TUNEL) labeling
TUNEL assay was performed on myocardial slices fixed in buffered formalin and processed for histological examination.
Electrophoresis and Western blot analysis
Homogenates, cytosolic and mitochondrial fractions were prepared from the pulverized ventricular tissue of the perfused hearts [2, 7] . Proteins from cardiac homogenates were probed with antibodies raised against Ser 16 and Thr17-phosphorylated PLN, total PLN, Ser2815 and Ser2809-phosphorylated ryanodine receptor (RyR2), total RyR2, active caspase-3, Bcl-2 and Bax. To assess cytochrome c release, mitochondria were separated from cytosol using the Cytochrome c Releasing Apoptotic assay Kit (Biovision Research Products, Mountain View, CA).
Cytochrome c oxidase activity and mitochondrial swelling
Mitochondrial cytochrome c oxidase activity was assayed with a commercial kit (Cytocox1, Sigma, St. Louis, Mo) according to manufacturer's instructions. Mitochondrial swelling was determined by light scattering at 520 nm in a spectrophotometer.
Statistical analysis
Data are expressed as mean ± SEM. Unpaired, paired Student t-test or ANOVA followed by Tukey post test were used for statistical comparisons when appropriate. Differences were considered significant at P b 0.05. Fig. 1 depicts the mechanical recovery and the degree of necrosis and apoptosis of rat hearts submitted to IR (45/120 min) in the presence or absence of 2.5 μM of the CaMKII inhibitor KN-93. Fig. 1A shows that the contractile recovery significantly increased whereas the infarct size and necrosis, evaluated by TTC staining and LDH release, respectively, significantly decreased in the presence of CaMKII-inhibition. Fig. 1B , C shows that CaMKII-inhibition also diminished apoptosis, as evidenced by the decrease in TUNEL positive nuclei, the ratio of proapoptotic protein Bax vs. antiapoptotic protein Bcl-2 (Bax/Bcl-2) and the activation of caspase-3, the end effector of apoptosis. The protective action of CaMKII-inhibition was specific, since KN-92, the inactive analogue of KN-93, was unable to prevent the apoptotic effect and to diminish the infarct size produced by IR. In the presence of KN-92, TUNEL positive nuclei and infarct size were 3.45 ± 0.8% of total nuclei number and 56.4 ± 3.72 % of risk area, respectively, being the values in the absence of the drug 3.53 ± 0.59 and 59.4 ± 7.48%, respectively. Moreover, recovery of the contractile function after 120 min of reperfusion was similarly depressed and not statistically different from the recovery in the absence of KN-92 (1.80 ± 0.35 and 3.17 ± 0.51 mm Hg, respectively, n = 3-7). A direct inhibitory effect of KN-93 on I Ca which may contribute to decrease apoptosis and necrosis independently of CaMKII, may be discarded from these results, since this effect of KN-93 on I Ca is shared by its inactive analog KN-92 [16] . These results indicate the protective role of CaMKII inhibition in the irreversible IR injury, confirming previous findings from our own laboratory [11] .
Results
Protective role of CaMKII inhibition in the irreversible IR injury
In additional experiments we studied the time course of the phosphorylation of Thr 17 site of PLN, a typical CaMKII substrate. association with a significant increase in the mechanical recovery after the protocol of IR. Panel B, shows that NCX inhibition also decreased infarct size, LDH release and apoptosis produced by IR injury. Taken together these experiments indicate that the reverse NCX mode is a major pathway of Ca 2+ influx upon reperfusion able to activate CaMKII. Thus, the NCX appears as the first step in the CaMKII cascade of events that produced cell death in IR.
The SR plays a major role in IR injury
To assess the role of the SR in the signalling cascade involved in the IR injury, we repeated the protocol of IR in the presence and absence of thapsigargin, to block SR Ca 2+ -ATPase (SERCA2a) and dantrolene to inhibit ryanodine and IP3 receptors. Fig. 3 shows that both drugs decreased the infarct size (A) and apoptosis assessed by the TUNEL technique (B). These experiments support a crucial role of SR Ca 2+ on the deleterious effect of IR, in agreement with previous results [11, 17, 19] .
CaMKII-mediated SR phosphorylations are involved in IR injury
To further investigate whether the deleterious effect of CaMKII was due to a CaMKII-dependent phosphorylation of SR proteins, TG mice with CaMKII inhibition targeted to the SR (SR-AIP mice) were subjected to IR. shows immunoblots and overall results indicating that the phosphorylation of Ser2815 of RyR2 significantly decreased at the onset of reperfusion (3 min) in association with a proportional decrease in the amount of RyR2. Consequently, the ratio P-Ser2815/RyR2 did not change significantly. No changes in Ser2809/RyR2 phosphorylation were detected (not shown). These results suggested that the phosphorylation of RyR2 is not a good candidate to explain the CaMKII-dependence of the deleterious effects of CaMKII on IR.
The mitochondria as the final effector of CaMKII-induced apoptosis and necrosis in IR injury
Previous experiments showed a closed coupling between ER/SR Ca 2+ release and mitochondrial Ca 2+ uptake [20] [21] [22] [23] . In the following group of experiments we first investigated the participation of mitochondria on IR injury and then the possible involvement of mitochondria in the CaMKII-mediated cascade of apoptosis/necrosis in IR. To address the first purpose, experiments were performed in the presence and absence of the mitochondrial Ca 2+ uniporter inhibitor rutenium red (RR, 5 μM) and the more specific one, Ru 360 (RU, 1 μM). has been associated with the release of apoptogenic factors, like cytochrome c, through the opening of the mitochondrial permeability transition pore (mPTP) [24] . We therefore performed experiments in the presence of the mPTP inhibitor, cyclosporine A (0.2 μM). Similarly to the inhibition of the mitochondrial Ca 2+ uniporter, inhibition of mPTP resulted in amelioration of the infarct size and apoptosis (Fig. 5A, B) . Taken together, these experiments confirmed previous results regarding the participation of mitochondria in IR injury, delineating a cascade which involves mitochondrial Ca 2+ uniporter and the mPTP. To study whether CaMKII was involved in the apoptotic effects of IR mediated by mitochondria, the release of cytochrome c was measured in the absence and presence of CaMKII-inhibition. Fig. 5C shows that the release of cytochrome c by the mitochondria was significantly decreased in the presence of KN-93 compared to hearts submitted to IR in the absence of KN-93. These experiments support a key role of mitochondria in the deleterious cascade initiated by CaMKII activation. The prevention of both mitochondrial Ca 2+ overload and activation of mPTP is critical to preserve mitochondrial integrity and to avoid irreversible cardiomyocyte damage. We therefore performed additional experiments to investigate whether CaMKII inhibition protects from mitochondrial damage following IR by measuring the activity of cytochrome c oxidase in the presence and absence of KN-93. Cytochrome c oxidase is integral to the inner mitochondrial membrane and therefore its activity is undetectable in intact mitochondria unless a detergent, e.g. n-dodecyl-β-maltoside, is added. Fig. 6A shows a significant increase in the activity of cytochrome c oxidase unmasked by the detergent, suggesting that a higher number of intact mitochondria were isolated from hearts subjected to IR in the presence of KN-93. Another indicator of mitochondrial integrity is the tolerance to Ca 2+ -induced swelling due to the opening of mPTP. KN-93 produced a 2.5 fold decrease in the rate of mPTP-related mitochondrial swelling compared to IR in the absence of the inhibitor (Fig. 6B ). Cyclosporine A (CsA) decreased Ca 2+ -induced mitochondrial swelling both in the presence and absence of KN-93, indicating that the observed changes resulted from mPTP activity (Fig. 6B) . KN-93 did not affect the activity of cytochrome c oxidase or mitochondrial swelling in control hearts (data not shown). These results suggest that CaMKII inhibition prevented the assembly of the mPTP and preserved the integrity of mitochondria during IR. Collectively, these findings indicate that mitochondrial Ca 2+ overload plays a role in the IR injury observed. More important to the aim of the present study, the results further show that cytochrome c release and Ca 2+ -induced mitochondrial swelling were both significantly diminished in the presence of CaMKII-inhibition (Figs. 5C and 6B), pointing to the mitochondria as the final effector of the CaMKII-dependent signalling pathway leading to irreversible IR injury.
The death receptor pathways of apoptosis
Caspase-8 activation is thought to be a major step in the extrinsic (death-receptor-dependent) apoptotic pathway [25] . Moreover, recent studies in cultured macrophages suggested a link among different apoptotic pathways evoked by ER-stress, in which CaMKII would play a pivotal role [26] . We therefore studied a possible participation of the extrinsic apoptotic pathway in the CaMKIIdependent-induced apoptosis/necrosis in IR, by exploring the activity of caspase-8 in the presence and absence of CaMKII-inhibition. It was found that the activity of caspase-8 was increased at the end of the reperfusion period. This increase could not be prevented however by KN-93 (IR: 218.1 ± 19.8 vs. IR+KN: 199.1 ± 23.0 expressed as % of the signal obtained in control hearts, not submitted to IR, n = 5). These results suggest that the intrinsic mitochondrial pathway appears as the sole route toward apoptosis mediated by CaMKII in cardiac IR.
Discussion
The present results describe a cascade of events during IR that involves CaMKII and leads to necrotic and apoptotic cell death. Previous studies, including findings from our own laboratory, have related CaMKII to apoptosis and necrosis in the context of IR injury [10, 11] . However the signalling cascade involved in this effect was not previously assessed. Our results indicate that CaMKII does not participate in the extrinsic cascade of apoptosis but is involved in the intrinsic (mitochondrial) pathway. They further show that this signalling pathway involves sequential activation of the reverse NCX mode, CaMKII and the CaMKII-dependent phosphorylation of SR protein(s), mitochondria Ca 2+ overload, cytochrome c release and caspase-3 activation. Interestingly, the cascade of events described mediates not only the programmed cell death known as apoptosis but also a CaMKII-dependent programmed necrosis.
NCX mediates the increase in CaMKII activity at the onset of reperfusion
The present study showed that in the irreversible IR injury, activation of CaMKII occurred at least in part by Ca 2+ influx through the reverse NCX mode. Inhibition of this mode of the exchanger with KBR leads to a decrease in the infarct size, LDH release and the number of apoptotic cells, supporting a major role of the exchanger as a mechanism of cell death in IR. Different reports showed the beneficial effects produced by treatment with NCX inhibitors on ischemic/ reperfused hearts [17, 18, 27] . However, the mechanisms underlying this cardioprotective effect remain unclear. It was proposed that during reperfusion, the Ca 2+ influx through the NCX induces the release of Ca 2+ from an overloaded SR. This effect would mediate the cytosolic Ca 2+ oscillations responsible for reperfusion injury in myocytes [17, 27] . The present experiments add to this previous mechanism another deleterious pathway triggered by the NCX, i.e. the increase in the activity of CaMKII, which initiates the sequence of events that produce CaMKII-mediated apoptosis and necrosis in the irreversible IR injury.
CaMKII-dependent phosphorylations of SR are central to the mechanism of necrosis/apoptosis in IR injury
Our results showed the participation of the SR and CaMKIIdependent SR phosphorylations in the CaMKII-dependent IR-induced apoptotic and necrotic pathway, by two different and complementary approaches: (1) pharmacological inhibition of SERCA2a (SR Ca 2+ load) and RyR2 (SR Ca 2+ release); and (2) IR protocols on transgenic mice with inhibition of CaMKII, targeted to the SR. The first approach points to the SR as a central player in the myocyte death pathway due to IR, in agreement with previous results that indicate that the SR is an integral component of inducible apoptosis in different pathological situations [28] . The second approach allows us to conclude that amelioration of the deleterious effect of IR is at least in part due to CaMKII-dependent phosphorylation of SR proteins. To the best of our knowledge, this is the first report clearly showing the importance of CaMKII-dependent phosphorylation of SR proteins not only in the apoptotic but also in the necrotic myocyte death of IR hearts. Inhibition of CaMKII in the SR-AIP mice was targeted to the SR. However, it was found that these mice also present an inhibition of I Ca facilitation [29] , which may contribute to the decrease in apoptosis/ necrosis observed in SR-AIP animals. Although the present findings cannot completely rule out a CaMKII-dependent increase in Ca 2+ entry via I Ca at the onset of reperfusion, this possibility would not oppose to the main role of CaMKII and the SR in the apoptotic and necrotic pathway of IR described in the present experiment. Moreover, a possible increase in I Ca , although may favour an increase in SR Ca 2+ load at the onset of reflow, would not contribute to CaMKII activation, since blockade of the L-type Ca 2+ channels with nifedipine failed to prevent the increase in CaMKII activity which, in contrast, was prevented by KBR (Fig 2) , at a concentration that does not affect basal myocardial contractility (See Table 1 in supplement data).
PLN as a possible participant in the deleterious effect mediated by CaMKII in IR
Although in the present study Thr 17 site phosphorylation was used as a tool to examine CaMKII activation, owing to the fact the PLN is one of the major SR-Ca 2+ handling proteins, it is tempting to speculate that phosphorylation of PLN might contribute to the deleterious effect of CaMKII in IR. Indeed, previous experiments support the relevance of CaMKII-dependent PLN phosphorylation in the damage caused by ischemia: AC3 transgenic mice expressing a CaMKII inhibitory peptide and submitted to myocardial infarction, showed a decreased number of apoptotic cells. This protection was absent in interbred AC3 mice with phospholamban-knockout (PLN −/− ) mice [10] . Moreover, recent experiments performed in transiently transfected HEK 293 cells described that the antiapoptotic effect of the protein HAX-1 would be due to modulation of SERCA2a expression and ER Ca 2+ levels [30] . Other studies, however, point to a beneficial rather than detrimental effect of PLN, particularly Thr 17 site, in IR. As mentioned above, previous studies of our own laboratory have clearly demonstrated the importance of Thr 17 phosphorylation on amelioration of Ca 2+ mishandling during reperfusion after a short ischemic period [9] .
It has also been shown that PKG-dependent PLN phosphorylation was cardioprotective in simulated IR in isolated myocytes [31] . More recent results further reveal that the beneficial effect of inhibitor-1 on IR injury occurs through the increase in Thr 17 site of PLN [32] . Thus, the role of PLN phosphorylation on IR remains elusive. These controversial results seem not to arise from species differences, since most of the experiments mentioned above referred to rodents. As previously suggested, the final beneficial or detrimental outcome of PLN phosphorylation might tightly depend on the extent of Ca 2+ uptake and SR Ca 2+ load achieved during ischemia and at the onset of reperfusion. For instance, moderate increases in SR Ca 2+ content have been associated with beneficial effects [32] , whereas more important increases, as those expected in PLN −/− mice, were associated with detrimental actions [10] .
Possible role of RyR2 in the deleterious effect mediated by CaMKII in IR
RyR2 is also a substrate of CaMKII at Ser2815 residue. This phosphorylation has been associated with an increase in Ca 2+ leak from the SR [33] , which may favour mitochondrial Ca 2+ overload (See below). Experiments wherein hearts were frozen at 1-3 min of reperfusion-the moment at which CaMKII appears to be active-failed to show any significant increase in the phosphorylation of Ser2815 site of RyR2. Thus a role of phosphorylation of RyR2 in the CaMKII-cascade of necrosis and apoptosis in IR is not supported by the present experiments. It should be noted, however, that RyR2 may contribute to this deleterious cascade by alternative mechanisms, unrelated to phosphorylation. For instance, earlier experiments described a decrease in RyR2 expression during cardiac ischemia-similar to that observed by us at the onset of reperfusion-associated with an increase in the rate of SR Ca 2+ release. This paradoxical result was explained by an ischemic damage of RyR2 leading to an increase in the open probability and/or conductance of Ca 2+ -release channels [34] , which might favour diastolic Ca 2+ leak. Redox alterations at the onset of reperfusion might also influence the activity of RyR2 and SR Ca 2+ leak [35] . Moreover, since acidosis is a main component of ischemia, an increase in SR Ca 2+ leak at the beginning of reperfusion might also occur due to the relief of RyR2 from the previous inhibition exerted by acidosis [36] . The possible role of these putative mechanisms remains to be explored.
The mitochondria as the end effector of the CaMKII-dependent necrotic and apoptotic pathway
The results of the present experiments indicate in the first place that mitochondria, possibly by an increase in mitochondrial Ca 2+ overload, are involved in the pathways of necrosis/apoptosis produced by IR. Secondly, and more important to the aim of the present manuscript, that mitochondria are involved in the CaMKIIdependent programmed pathway of cell death produced by IR. We showed that CaMKII-inhibition by KN [20, 37] . In line with this idea, a recent publication described a direct effect of SR on mPTP and cell death in intact cardiac myocytes in the context of IR [23] . Whereas both necrosis and apoptosis have been shown to contribute to cell death induced by myocardial IR, necrosis appears to be the main component of cell death at least immediately after reperfusion [38] . Our results showing a decrease in infarct size and LDH release in the presence of thapsigargin or dantrolene or in the AIP-transgenic mice indicated that similar conclusions to those discussed for the apoptotic cascade can be drawn for the necrotic pathway, underscoring the fact that the necrotic cell death is also mediated by CaMKII and includes the mitochondria as the final step. This striking finding is quite remarkable and is in line with recent reports challenging the concept of necrotic death as a chaotic unregulated process [39] . Finally, our results demonstrated that although activation of caspase-8 occurred during IR, CaMKII was not involved in the extrinsic apoptotic pathway.
Limitations of the study
The present experiments proposed alterations in Ca 2+ handling at different intracellular levels. These conclusions were based on specific inhibition of the main proteins responsible for Ca 2+ movements at these particular levels and not on direct measurements of intracellular Ca
2+
. Alterations of Ca 2+ handling in line with those suggested in the present manuscript, have been previously documented [11, 17, 23] .
The main objective of the present manuscript was to describe the signalling cascade that involves CaMKII activation and leads to apoptosis/necrosis, during IR. Finally, this study was performed in the intact heart in ex vivo conditions. These conditions are more suitable to reproduce in vivo IR injury than isolated myocytes; we are aware however that they do not completely reproduce the in vivo situation. Nonetheless, it is expected that identification of a previously undefined cascade by which CaMKII leads to apoptosis and necrosis in IR injury under the controlled conditions of the present experiments, gives strong support to future research in vivo and in the clinical setting.
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